Clevira, an antiviral formulation received Government of India regulatory approval as a supportive treatment for mild to moderate COVID-19 cases.
Formulation has shown 86% recovery rate on the 5th day of the treatment & 100% recovery by Day 10. Safe for people with kidney and liver ailments. Can be used as a prophylactic treatment by caregivers and frontline workers. Important to follow Covid Appropriate Behaviors. Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for …